SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-22-019770
Filing Date
2022-07-29
Accepted
2022-07-29 07:21:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 xfor424b3.htm 424B3 107345
2 image_0.jpg GRAPHIC 3709
  Complete submission text file 0001628280-22-019770.txt   113667
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-264459 | Film No.: 221117368
SIC: 2836 Biological Products, (No Diagnostic Substances)